Daniel Sasca

996 total citations
20 papers, 473 citations indexed

About

Daniel Sasca is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Daniel Sasca has authored 20 papers receiving a total of 473 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Hematology and 4 papers in Genetics. Recurrent topics in Daniel Sasca's work include Acute Myeloid Leukemia Research (10 papers), Protein Degradation and Inhibitors (7 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). Daniel Sasca is often cited by papers focused on Acute Myeloid Leukemia Research (10 papers), Protein Degradation and Inhibitors (7 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). Daniel Sasca collaborates with scholars based in Germany, United States and United Kingdom. Daniel Sasca's co-authors include Thomas Kindler, Matthias Theobald, Patricia S. Hähnel, Lars Bullinger, Oliver Kriege, George S. Vassiliou, Brian J.P. Huntly, Haiyang Yun, Paolo Gallipoli and George Giotopoulos and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Daniel Sasca

19 papers receiving 468 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Sasca Germany 8 307 210 89 73 58 20 473
Jörg Mengwasser Germany 8 466 1.5× 70 0.3× 46 0.5× 131 1.8× 70 1.2× 12 587
Sarah Swerdlow United States 5 172 0.6× 189 0.9× 36 0.4× 52 0.7× 36 0.6× 10 386
Laura Quotti Tubi Italy 10 275 0.9× 118 0.6× 34 0.4× 114 1.6× 52 0.9× 21 411
Jingrong Xian China 11 183 0.6× 79 0.4× 77 0.9× 42 0.6× 29 0.5× 13 261
Le Xuan Truong Nguyen United States 12 319 1.0× 101 0.5× 82 0.9× 81 1.1× 39 0.7× 30 416
Juan Luiz Coelho‐Silva Brazil 10 155 0.5× 78 0.4× 52 0.6× 43 0.6× 25 0.4× 35 264
Jennifer S. Carew United States 3 283 0.9× 38 0.2× 31 0.3× 60 0.8× 45 0.8× 4 412
Samuele Gherardi Italy 13 538 1.8× 26 0.1× 184 2.1× 176 2.4× 35 0.6× 20 730
Srilatha Nalluri United States 9 296 1.0× 85 0.4× 61 0.7× 61 0.8× 28 0.5× 9 369
Kati Servan Germany 6 224 0.7× 69 0.3× 105 1.2× 119 1.6× 27 0.5× 6 389

Countries citing papers authored by Daniel Sasca

Since Specialization
Citations

This map shows the geographic impact of Daniel Sasca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Sasca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Sasca more than expected).

Fields of papers citing papers by Daniel Sasca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Sasca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Sasca. The network helps show where Daniel Sasca may publish in the future.

Co-authorship network of co-authors of Daniel Sasca

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Sasca. A scholar is included among the top collaborators of Daniel Sasca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Sasca. Daniel Sasca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Perner, Florian, Tobias Berg, Daniel Sasca, et al.. (2025). Therapeutic targeting of chromatin alterations in leukemia and solid tumors. International Journal of Cancer. 158(2). 382–408. 1 indexed citations
2.
Kuykendall, Andrew, Naveen Pemmaraju, Kristen Pettit, et al.. (2025). Results from VERIFY, a phase 3, double-blind, placebo (PBO)-controlled study of rusfertide for treatment of polycythemia vera (PV).. Journal of Clinical Oncology. 43(17_suppl).
3.
Pettit, Kristen, Joseph J. Shatzel, Abdulraheem Yacoub, et al.. (2024). VERIFY: A randomized controlled phase 3 study of the hepcidin mimetic rusfertide (PTG-300) in patients with polycythemia vera (PV).. Journal of Clinical Oncology. 42(16_suppl). TPS6592–TPS6592. 1 indexed citations
4.
Jilg, Stefanie, Juliana Schwaab, Katja Sockel, et al.. (2024). MoReLife – real-life data support the potential of momelotinib as a safe and effective treatment option for cytopenic myelofibrosis patients. Annals of Hematology. 103(10). 4065–4077. 1 indexed citations
5.
Agrawal‐Singh, Shuchi, George Giotopoulos, Sarah J. Horton, et al.. (2022). HOXA9 forms a repressive complex with nuclear matrix–associated protein SAFB to maintain acute myeloid leukemia. Blood. 141(14). 1737–1754. 5 indexed citations
6.
Bohl, Stephan, Catharina Lahrmann, Linda Kessler, et al.. (2022). The Menin Inhibitor Ziftomenib (KO-539) Synergizes with Agents Targeting Chromatin Regulation or Apoptosis and Sensitizes AML with MLL Rearrangement or NPM1 Mutation to Venetoclax. Blood. 140(Supplement 1). 6226–6227. 1 indexed citations
7.
Witte, Ines, Andrea Schüler, Piyush More, et al.. (2021). Deficiency of Antioxidative Paraoxonase 2 (Pon2) Leads to Increased Number of Phenotypic LT‐HSCs and Disturbed Erythropoiesis. Oxidative Medicine and Cellular Longevity. 2021(1). 3917028–3917028. 3 indexed citations
8.
Sasca, Daniel, Borhane Guezguez, & Michael W.M. Kühn. (2021). Next generation epigenetic modulators to target myeloid neoplasms. Current Opinion in Hematology. 28(5). 356–363. 2 indexed citations
9.
Sasca, Daniel, Gerard M. McGeehan, Chun‐Wei Chen, et al.. (2020). Synergistic targeting of FLT3 mutations in AML via combined menin-MLL and FLT3 inhibition. Blood. 136(21). 2442–2456. 79 indexed citations
10.
Theobald, Matthias, et al.. (2020). Treatment-Induced Aggravation of Vasculitis in Hairy-Cell Leukemia. Clinical Lymphoma Myeloma & Leukemia. 21(5). e429–e431. 1 indexed citations
11.
Yun, Haiyang, Shabana Vohra, Annalisa Mupo, et al.. (2019). Mutational Synergy Coordinately Remodels Chromatin Accessibility, Enhancer Landscape and 3-Dimensional DNA Topology to Alter Gene Expression during Leukemia Induction. Blood. 134(Supplement_1). 278–278. 2 indexed citations
12.
Sasca, Daniel, Haiyang Yun, George Giotopoulos, et al.. (2019). Cohesin-dependent regulation of gene expression during differentiation is lost in cohesin-mutated myeloid malignancies. Blood. 134(24). 2195–2208. 39 indexed citations
13.
Sasca, Daniel, Andrea Schüler, Jan B. Heidelberger, et al.. (2019). NCAM1 (CD56) promotes leukemogenesis and confers drug resistance in AML. Blood. 133(21). 2305–2319. 52 indexed citations
14.
Gallipoli, Paolo, George Giotopoulos, Konstantinos Tzelepis, et al.. (2018). Glutaminolysis is a metabolic dependency in FLT3ITD acute myeloid leukemia unmasked by FLT3 tyrosine kinase inhibition. Blood. 131(15). 1639–1653. 101 indexed citations
15.
Huntly, Brian J.P., Sarah J. Horton, George Giotopoulos, et al.. (2016). Early Loss of CREBBP Confers Malignant Stem Cell Properties on Lymphoid Progenitors. Blood. 128(22). 460–460. 4 indexed citations
16.
Sasca, Daniel, et al.. (2015). Targeting Aberrant Ncam (neural cell adhesion molecule; CD56) Expression in Acute Myeloid Leukemia. Blood. 126(23). 311–311. 1 indexed citations
17.
Sasca, Daniel, Patricia S. Hähnel, Oliver Kriege, et al.. (2014). SIRT1 prevents genotoxic stress-induced p53 activation in acute myeloid leukemia. Blood. 124(1). 121–133. 90 indexed citations
18.
Hähnel, Patricia S., Daniel Sasca, Wynand P. Roos, et al.. (2014). Targeting components of the alternative NHEJ pathway sensitizes KRAS mutant leukemic cells to chemotherapy. Blood. 123(15). 2355–2366. 35 indexed citations
19.
Weber, Michael, Daniel Sasca, Daniel Teschner, et al.. (2013). Distinct Signaling Cascades of TREM-1, TLR and NLR in Neutrophils and Monocytic Cells. Journal of Innate Immunity. 6(3). 339–352. 29 indexed citations
20.
Tam, Winnie F., Patricia S. Hähnel, Andrea Schüler, et al.. (2012). STAT5 Is Crucial to Maintain Leukemic Stem Cells in Acute Myelogenous Leukemias Induced by MOZ-TIF2. Cancer Research. 73(1). 373–384. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jörg Mengwasser Breakdown of academic impact, for papers by Sarah Swerdlow Breakdown of academic impact, for papers by Laura Quotti Tubi Breakdown of academic impact, for papers by Jingrong Xian Breakdown of academic impact, for papers by Le Xuan Truong Nguyen Breakdown of academic impact, for papers by Juan Luiz Coelho‐Silva Breakdown of academic impact, for papers by Jennifer S. Carew Breakdown of academic impact, for papers by Samuele Gherardi Breakdown of academic impact, for papers by Srilatha Nalluri Breakdown of academic impact, for papers by Kati Servan
Rankless by CCL
2026